CancerCareCoin - Key Item 9
CancerCareCoin: Powering the Ecosystem
CancerCareCoin is the heartbeat of the Cancer Care Hub, a first-of-its-kind token blending meme coin accessibility with real-world impact for cancer patients, caregivers, and researchers. Built on the Solana blockchain, it promotes awareness, funds research, and rewards community participation through a transparent, secure ecosystem.
With a total supply of 1 billion tokens and an initial price of $0.00025, CancerCareCoin offers affordable entry for supporters, targeting a $250,000 initial market cap with 4x growth potential. Its distribution ensures impact: 15% is locked for cancer research, 10% funds warrior awards for patients and caregivers, and 5% provides VR headsets and devices to enhance patient experiences. Anti-pump-and-dump measures, including a multi-signature treasury, 6-month team vesting cliff, and 80% liquidity locked for two years, protect token integrity.
CancerCareCoin incentivizes engagement—patients earn tokens by mentoring peers, while donors and enterprises fund research and support through transparent contributions. Future plans include cross-chain integration and partnerships with treatment centers to make the Connect App the primary global destination for cancer care. Governed by community votes and audited smart contracts, CancerCareCoin ensures every token drives hope, research, and support for cancer warriors worldwide.
Name: CancerCareCoin
Finalize name beginning Q2 2025 to resolve brand, trademark, copyright conflicts. See trademark page.
Purpose
Promote cancer awareness, research, and patient/caregiver rewards through a decentralized blockchain ecosystem, connecting patients, caregivers, and providers to make the Connect App the primary global destination for cancer care with enterprise solutions.
Token Distribution (1 billion tokens)
40% - Public sale/liquidity ($100,000 at $250,000 cap, $400,000 at $1M cap, supporting $1M market cap by October 15, 2025; 10% allocated to enterprise development, $40,000; unallocated portion for future initiatives).
15% - Cancer research donation fund (locked, $37,500 at $250,000, $150,000 at $1M, $1M at $6.67M cap by 2027).
16% - Founding team (6-8 founders at 2%, with vesting).
8% - Warrior awards ($25,000 at $250,000, $100,000 at $1M, funding 10,000 tokens/user [$2.50 at $0.00025] for peer support, advocacy, and engagement, supporting 50,000 users in 2025).
10% - Marketing and partnerships ($25,000 at $250,000, $100,000 at $1M, targeting 10 languages and 2 NGO partners in 2025).
5% - Capital equipment (VR headsets and other tools, e.g., telehealth devices, $12,500 at $250,000, $50,000 at $1M; 1,000 headsets [$300,000] by Q4 2025 via partnerships).
6% - Operational expenses.
Token Issuance Strategy
Total Token Supply: 1 billion tokens, initial price $0.00025, launching July 15, 2025, targeting $1 million market cap by October 15, 2025 (minimum $500,000), with $6.67 million by 2027 to fund $1 million in research and $500,000 in enterprise revenue.
Initial Pricing: $0.00025 for $250,000 market cap, offering 4x upside to $0.001 ($1M) and a “journey to a penny” ($0.01, 40x).
Future Issuance: 5% annual inflation cap after year 2, requiring 5/7 or 6/8 founder approval and community vote, restricted to warrior awards, partnerships, or protocol development.
Marketing: 10-week onramp (May 5-July 15, 2025) with $100,000 (10% at $1M cap), amplified by multilingual campaigns in 10 languages (e.g., English, Spanish, Mandarin), 2 NGO partnerships, and enterprise pilot promotions in 2025 to reach 50,000 Connect App users as the primary global destination for cancer care.
Founder recruitment launch May 5, 2025, concluding by June 15, 2025, to ensure team readiness for warrior awards, equipment, and enterprise solutions.
Roadmap
CancerCareCoin follows a phased approach to deliver impact:
Phase 1 (Q3 2025):
Launch July 15, 2025, with $80,000-$250,000 liquidity.
Target $1M market cap by October 15.
Secure 2 NGO partners (e.g., Myeloma UK, https://www.myeloma.org.uk).
Found 6-8 founders by June 15.
Phase 2 (Q4 2025):
Deploy Connect App to 50,000 users.
Expand warrior awards ($100,000).
Deliver 1,000 VR headsets ($300,000).
Secure 1-2 enterprise pilots ($50,000 revenue).
Phase 3 (Q4 2026-2027):
Enable cross-chain integration.
Partner with 10 treatment centers.
Secure 3-5 enterprise contracts ($200,000 revenue) for 1 million users.
Phase 4 (2027):
Achieve $1M in cancer research funding.
Generate $500,000 in enterprise revenue.
Reach 1 million Connect App users.
Founder Allocation & Investment Structure
Founders should have skin in the game to align incentives and enhance credibility.
Token Allocation: 16% total (2% per founder for 6-8 founders), with a 6-month cliff and 24-month linear vesting.
Demographic: High-caliber, diverse team (40-50% female/non-binary, 3+ continents, 30-60 years), including blockchain developers, healthcare experts, cancer survivors, marketing leaders, enterprise solutions specialists, financial/legal advisors, and community advocates.
Required Investment: $5,000-$10,000 per founder ($30,000-$80,000 total for 6-8 founders), secured by June 15, 2025.
Use: Fund initial liquidity pool ($80,000-$250,000), smart contract audits ($5,000-$10,000), and enterprise development ($40,000).
Implementation: Formal agreements for investment and responsibilities; anonymized wallet addresses published for transparency. Recruitment launched May 5, 2025, with selection by June 15, 2025.
Learn more about our founder search, and apply to join our founding team by May 19, 2025. ENQUIRE HERE
This balanced approach ensures founders are appropriately invested while maintaining a fair token allocation that rewards their work building the project.
CancerCareCoin’s 1 billion token supply is allocated to drive impact, as shown. With 40% for public sale and liquidity, 15% locked for cancer research, and 8% for Warrior Awards, the token ensures transparency, supported by 6% operational expenses and 5% for VR headsets.[Figure 1: CancerCareCoin Token Allocation, 2025]
